GOG-0225

Closed to Accrual

Return to Protocol Table

Protocol Information

Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants

Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?

Principal Investigator

David S. Alberts

Status

Closed to Accrual

Open to Accrual

June 18, 2012

Closed to Accrual

August 24, 2018


Disease Site

Gynecologic [GY] Ovarian

Phase

Other

Developmental Therapeutics

No

Primary Objective

To determine if women who are disease free after successfully completing primary and potential consolidation/maintenance, therapy for Stage II-IV ovarian, fallopian tube or primary peritoneal cancer and who are randomized to a healthy lifestyle intervention, will have significantly increased progression free survival compared to similar women who are randomized to a usual care comparison group.

Patient Population

Women who are disease free after successfully completing primary and potential consolidation/maintenance, therapy for Stage II-IV ovarian, fallopian tube or primary peritoneal cancer and who are randomized to a healthy lifestyle intervention and similar women who are randomized to a usual care comparison group.

Target Accrual

1150


Protocol Document

Patient Study Webpage

There is no available patient study webpage available for this trial at this time.